Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;46:1236-1242
Published online before print November 14, 2005, doi: 10.1161/01.HYP.0000193538.20705.23
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/6/1236    most recent
01.HYP.0000193538.20705.23v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dielis, A. W.J.H.
Right arrow Articles by de Leeuw, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dielis, A. W.J.H.
Right arrow Articles by de Leeuw, P. W.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Other hypertension
Right arrow Coagulation and fibronolysis

(Hypertension. 2005;46:1236.)
© 2005 American Heart Association, Inc.


Brief Review

The Prothrombotic Paradox of Hypertension

Role of the Renin-Angiotensin and Kallikrein-Kinin Systems

Arne W.J.H. Dielis; Machiel Smid; Henri M.H. Spronk; Karly Hamulyak; Abraham A. Kroon; Hugo ten Cate; Peter W. de Leeuw

From the Department of Medicine, University Hospital Maastricht and Cardiovascular Research Institute Maastricht, University of Maastricht, The Netherlands.

Correspondence to Peter W. de Leeuw, MD, PhD, FAHA, Department of Medicine, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands. E-mail p.deleeuw{at}intmed.unimaas.nl

Despite increased pulsatile stress, thrombotic rather than hemorrhagic events represent a major complication of hypertension. The pathophysiology of thrombosis in hypertension involves the interaction among vascular endothelium and particularly the renin-angiotensin and kallikrein-kinin systems. Because hypertension is often associated with some degree of inflammation, the combination of chronic inflammation and chronic shear stress may convert the normal anticoagulant endothelium into a procoagulant surface, expressing tissue factor. Activation of the renin-angiotensin system leads to activation of nuclear factor {kappa}B–dependent proinflammatory genes, also accelerating the expression of tissue factor. Renin-angiotensin and kallikrein-kinin systems interact at several levels to modulate coagulation, fibrinolysis, and vasodilatation in such a way that these 2 systems could have a major influence on the occurrence of thrombotic complications. Treatment with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists may favorably influence the balance between the renin-angiotensin and kallikrein-kinin axis, regulating blood pressure as well as reducing the risk of thrombosis, which may explain part of the clinical efficacy of these drugs.


Key Words: renin-angiotensin system • kallikrein-kinin systems • blood pressure




This article has been cited by other articles:


Home page
HypertensionHome page
M. Masoud, G. Sarig, B. Brenner, and G. Jacob
Orthostatic Hypercoagulability: A Novel Physiological Mechanism to Activate the Coagulation System
Hypertension, June 1, 2008; 51(6): 1545 - 1551.
[Abstract] [Full Text] [PDF]